Company Information
USD
28.74
- (-0.8%)
NASDAQ:SUPN, SUPERNUS PHARMACEUTICALS, INC.
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 15 May 2024 GMT-4
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Address
9715 Key West Avenue
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - Specialty & Generic
Key Executives
Ms. Tami Tillotson Martin, Esq.,R.N.
Senior VP, Divisional
Mr. Charles W. Newhall, III
Chairman of the Board/Director
Mr. Frederick M. Hudson
Director
Dr. Georges Gemayel,PhD
Director
Mr. Timothy C. Dec
CFO/Chief Accounting Officer/Senior VP
Dr. John M. Siebert,PhD
Director
Mr. Jack A. Khattar
CEO/Director/Founder/President/Secretary
Dr. Jonathan Rubin, M.B.A.,M.D.
Chief Medical Officer/Senior VP
Dr. Carrolee Barlow, M.D.,PhD
Director
Ms. Bethany Sensenig
Director
Mr. Padmanabh P. Bhatt
Chief Scientific Officer/Senior VP, Divisional
Mr. Frank Mottola
Senior VP, Divisional
Ownership
Institution Holdings
BlackRock Inc
10,382,770 (18.969%)
BlackRock Fund Advisors
6,310,880 (11.530%)
Vanguard Group Inc
6,214,731 (11.354%)
Armistice Capital, LLC
4,650,000 (8.495%)
Macquarie Group Ltd
2,737,716 (5.002%)
Macquarie Investment Management Aus Ltd.
2,737,716 (5.002%)
Dimensional Fund Advisors, Inc.
2,456,369 (4.488%)
Macquarie Investment Management Advisers
2,087,071 (3.813%)
State Street Corporation
2,062,326 (3.768%)
Delaware Management Company
2,061,077 (3.766%)
Funds Holdings
iShares Core S&P Small-Cap ETF
3,731,930 (6.818%)
Delaware Small Cap Core Fund
2,061,077 (3.766%)
Vanguard US Total Market Shares ETF
1,646,356 (3.008%)
Vanguard Total Stock Market Index Fund
1,646,356 (3.008%)
Vanguard Small Cap Index
1,325,406 (2.422%)
Stephens SMID Select Growth
1,226,169 (2.240%)
iShares Russell 2000 ETF
1,208,060 (2.207%)
Vanguard Explorer Fund
1,007,005 (1.840%)
Vanguard Small Cap Value Index Fund
909,503 (1.662%)
Vanguard Institutional Extnd Mkt Idx Tr
801,348 (1.464%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
